Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSINOPRIL vs FRUQUINTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSINOPRIL vs FRUQUINTINIB: Safety Overview

Metric FOSINOPRIL FRUQUINTINIB
Total FAERS Reports 461 2,565
Deaths Reported 36 874
Death Rate 7.8% 34.1%
Hospitalizations 219 753
Average Patient Age 66.1 yrs 63.9 yrs
% Female Patients 41.5% 44.4%
FDA Approval Date Apr 20, 2005 Nov 8, 2023
Manufacturer Chartwell RX, LLC Takeda Pharmaceuticals America, Inc.
Route ORAL ORAL
Marketing Status Discontinued Prescription